Compare · COCH vs ISRG
COCH vs ISRG
Side-by-side comparison of Envoy Medical Inc. (COCH) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COCH and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $148.46B, about 3017.7x COCH ($49.2M).
- COCH has been more active in the news (4 items in the past 4 weeks vs 3 for ISRG).
- ISRG has more recent analyst coverage (25 ratings vs 3 for COCH).
- Company
- Envoy Medical Inc.
- Intuitive Surgical Inc.
- Price
- -
- -
- Market cap
- $49.2M
- $148.46B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2000
- News (4w)
- 4
- 3
- Recent ratings
- 3
- 25
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest COCH
- Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
- SEC Form 8-K filed by Envoy Medical Inc.
- Lake Street initiated coverage on Envoy Medical with a new price target
- Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
- SEC Form DEFA14A filed by Envoy Medical Inc.
- Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
- SEC Form DEF 14A filed by Envoy Medical Inc.
- Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by CAO & VP of Finance Potashnick Robert
- SEC Form PRE 14A filed by Envoy Medical Inc.
Latest ISRG
- SEC Form 4 filed by Intuitive Surgical Inc.
- SEC Form 4 filed by Intuitive Surgical Inc.
- Barclays initiated coverage on Intuitive Surgical with a new price target
- VP Corporate Controller Widman Fredrik exercised 1,089 shares at a strike of $94.52 and sold $407,765 worth of shares (1,089 units at $374.44) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $17,141 worth of shares (48 units at $357.10) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 764 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $24,671 worth of shares (69 units at $357.55) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 812 units (SEC Form 4)
- New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $59,439 worth of shares (154 units at $385.97) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 881 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $90,778 worth of shares (231 units at $392.98) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 1,035 units (SEC Form 4)
- Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen